Crabel Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$9.84M |
| 2 |
IAA
IAA, Inc. Common Stock
IAA
|
+$7.46M |
| 3 |
Vanguard Short-Term Bond ETF
BSV
|
+$6.83M |
| 4 |
AJRD
Aerojet Rocketdyne Holdings
AJRD
|
+$6.68M |
| 5 |
AIMC
Altra Industrial Motion Corp
AIMC
|
+$6.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$7.87M |
| 2 |
CCXI
ChemoCentryx, Inc.
CCXI
|
+$7.68M |
| 3 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
+$7.67M |
| 4 |
CYBE
Cyberoptics Corp
CYBE
|
+$7.61M |
| 5 |
FBC
Flagstar Bancorp, Inc. New
FBC
|
+$6.55M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.54% |
| 2 | Industrials | 9.14% |
| 3 | Healthcare | 6.98% |
| 4 | Financials | 5.64% |
| 5 | Consumer Discretionary | 5.16% |
Similar funds
Crabel Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, Crabel Capital Management held 119 positions worth $276M, up 61% from $171M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Crabel Capital Management deployed $97.5M of net new capital in Q4 2022, opening 69 new positions and adding to 4 existing holdings. Its largest new stake was Vanguard Short-Term Corporate Bond ETF: 131,715 shares worth $9.9M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 18% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $426K trimmed.
- Crabel Capital Management's largest Q4 2022 buy was Vanguard Short-Term Corporate Bond ETF: 131,715 shares worth $9.9M.
- Crabel Capital Management added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q4 2022, an estimated $4.66M increase.
- Crabel Capital Management's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $426K.
- Crabel Capital Management fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $7.87M.
- Crabel Capital Management's ten largest holdings make up 30% of its $276M portfolio in Q4 2022.
- Crabel Capital Management opened 69 new positions and closed 27 in Q4 2022.
- Crabel Capital Management's portfolio value rose 61% quarter-over-quarter to $276M.
Based on Crabel Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.